Gothenburg, Sweden

Margit Mahlapuu

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 29(Granted Patents)


Location History:

  • Göteborg, SE (2014 - 2018)
  • Solna, SE (2019 - 2020)
  • Gothenburg, SE (2019 - 2021)

Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Margit Mahlapuu: Innovator in Pharmaceutical Formulations

Introduction

Margit Mahlapuu is a notable inventor based in Gothenburg, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of chronic wounds and the prevention of post-surgical complications. With a total of 8 patents to her name, her work has the potential to impact many lives.

Latest Patents

Mahlapuu's latest patents include a pharmaceutical formulation for the treatment of chronic ulcers. This invention provides a formulation comprising LL-37 or a pharmaceutically-acceptable salt thereof, along with one or more pharmaceutically-acceptable diluents or carrier systems. This method is particularly useful for treating hard-to-heal venous leg ulcers and diabetic foot ulcers. Another significant patent involves hyaluronic acid-containing compositions aimed at preventing the formation of post-surgical scars and adhesions. This invention enhances the therapeutic effect of biologically active peptides, especially those derived from human lactoferrin, and is useful for treating and preventing wounds, scars, and post-surgical adhesions.

Career Highlights

Throughout her career, Margit Mahlapuu has worked with various companies, including Pergamum AB and Promore Pharma AB. Her innovative work in pharmaceutical formulations has positioned her as a key figure in her field.

Collaborations

Mahlapuu has collaborated with notable professionals such as Alvar Grönberg and Christine Dieterich, contributing to her success and the advancement of her inventions.

Conclusion

Margit Mahlapuu's contributions to pharmaceutical innovations demonstrate her commitment to improving healthcare outcomes. Her patents reflect her expertise and dedication to addressing critical medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…